Abstract
The initial clinical presentation of adrenocortical carcinoma (ACC) consists of signs and symptoms of hormone excess, local or regional manifestations of tumor growth, complications of metastatic disease, or more general manifestations of malignancy such as weight loss, fever, and malaise. Currently, an increasing number of patients is detected incidentally by modern imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abiven G et al (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91(7):2650–2655
Crucitti F et al (1996) The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119(2):161–170
Dackiw AP et al (2001) Adrenal cortical carcinoma. World J Surg 25(7):914–926
Icard P et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25(7):891–897
Kendrick ML et al (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136(5):543–549
Koschker AC et al (2006) Adrenocortical carcinoma – improving patient care by establishing new structures. Exp Clin Endocrinol Diabetes 114(2):45–51
Schulick RD, Brennan MF (1999) Adrenocortical carcinoma. World J Urol 17(1):26–34
Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72(11):3145–3155
Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23(2):273–289
Didolkar MS et al (1981) Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47(9):2153–2161
Favia G et al (2001) Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 25(6):735–738
Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112(6):963–970; discussion 970–971
Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92(5):1113–1121
Wajchenberg B et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4):711–736
Newell-Price J et al (2006) Cushing’s syndrome. Lancet 367(9522):1605–1617
Stewart PM et al (1995) 11 beta-Hydroxysteroid dehydrogenase activity in Cushing’s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 80(12):3617–3620
Moreno S et al (2004) Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases. Surgery 136(6):1192–1198
Gabrilove J et al (1965) Feminizing adrenocortical tumors in the male: a review of 52 cases including a case report. Medicine 44: 37–39
Lanigan D et al (1993) A feminizing adrenocortical carcinoma presenting with gynaecomastia. Postgrad Med J 69(812):481–483
Allolio B et al (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60:273–287
Seccia TM et al (2005) Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn’s syndrome with an ominous clinical course. Endocr Relat Cancer 12(1):149–159
Barzon L et al (2005) Shift from Conn’s syndrome to Cushing’s syndrome in a recurrent adrenocortical carcinoma. Eur J Endocrinol 153(5):629–636
Hisamatsu H et al (2002) Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence. BJU Int 90(9):971–972
Hyodo T et al (1977) Adrenocortical carcinoma and hypoglycemia: evidence for production of nonsuppressible insulin-like activity by the tumor. J Clin Endocrinol Metab 44(6):1175–1184
Luton JP et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322(17):1195–1201
Falchuk KR (1973) Inappropriate antidiuretic hormone-like syndrome associated with an adrenocortical carcinoma. Am J Med Sci 266(5):393–395
Yamanaka K et al (2000) A case of renin-producing adrenocortical cancer. Endocr J 47(2):119–125
Oka T et al (1996) Erythropoietin-producing adrenocortical carcinoma. Urol Int 56(4):246–249
Fragoso MC et al (2007) An inhibin B and estrogen-secreting adrenocortical carcinoma leading to selective FSH suppression. Horm Res 67(1):7–11
Pegoli W Jr. et al (1987) Ectopic calcitonin in adrenocortical carcinoma: a new tumor marker. J Pediatr Surg 22(12):1183–1184
Bussani R et al (2003) Chance diagnosis of low stage non-metastasized adrenal cortical carcinoma in a young woman with retroperitoneal hemorrhage. Pathol Res Pract 199(11):761–763
Suyama K et al (2007) Spontaneous rupture of adrenocortical carcinoma. Am J Surg 194(1):77–78
Chesson JP, Theodorescu D (2002) Adrenal tumor with caval extension – case report and review of the literature. Scand J Urol Nephrol 36(1):71–73
Hisham AN et al (2003) Large adrenocortical carcinoma extending into the inferior vena cava and right atrium. Asian J Surg 26(1):40–42
Radecka E et al (2003) An unusual case of tumor thrombus in the inferior vena cava. A case report. Acta Radiol 44(2):160–161
Yeh MW et al (2006) Virilizing adrenocortical carcinoma with cavoatrial extension. Am J Surg 192(2):209–210
Fassnacht M et al (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115(2):243–250
Bakthavathsalam G et al (2008) Nonfunctioning adrenocorticalcarcinoma. Int Surg 93(2):81–87
Brand TC et al (2001) Adrenal cortical carcinoma presenting as right varicocele. J Urol 165(2):503
Wright CB et al (2008) Adrenocortical tumor with left renal vein, vena cava and intrahepatic venous extension. J Cardiovasc Surg (Torino) 49(1):79–81
Carbonnel F et al (1988) Acute Budd-Chiari syndrome as first manifestation of adrenocortical carcinoma. J Clin Gastroenterol 10(4):441–444
Schteingart DE et al (2001) Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. J Clin Endocrinol Metab 86(8):3968–3974
Durusu M et al (2002) Adrenal cortical carcinoma presenting initially with radius metastasis. Clin Oncol (R Coll Radiol) 14(1):83–84
Solans R et al (2001) [Bone metastases as presentation of adrenocortical carcinoma]. Med Clin (Barc) 116(2):76–77
Macfarlane DA (1958) Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R C Surg Engl 23(3):155–186
Fassnacht M et al (2004) Adrenal tumors: how to establish malignancy? J Endocrinol Invest 27(4):387–399
Elamin MB et al (2008) Accuracy of Diagnostic Tests for Cushing’s Syndrome: a Systematic Review and Metaanalyses. J Clin Endocrinol Metab 93(5):1553–1562
Nieman LK et al (2008) The Diagnosis of Cushing’s Syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540
Boyle JG et al (2007) Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J Clin Endocrinol Metab 92(12):4602–4608
Eisenhofer G (2003) Editorial: biochemical diagnosis of pheochromocytoma – is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab 88(2):550–552
Pacak K et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3(2):92–102
Perry CG et al (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf) 66(5):703–708
Unger N et al (2006) Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154(3):409–417
Vaclavik J et al (2007) Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 25(7):1427–1431
Arlt W et al (2008) Steroid profiling in the diagnosis and monitoring of adrenocortical cancer – results of the EURINE ACC Study of the European Network For The Study Of Adrenal Tumors (ENS@T). Abstracts of the 90th annual meeting of the Endocrine Society (San Francisco): OR40-2
Johanssen S, et al (2010) Need for improvement in the clinical management of patients with adrenocortical carcinoma in Germany. Dt Aerzteblatt in press
Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027–2037
Friedrich-Rust M et al (2008) Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions. AJR Am J Roentgenol 191(6):1852–1860
Bauditz J et al (2008) Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound. Oncol Rep 19(5):1135–1139
Boland GW et al (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204
Caoili EM et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222(3):629–633
Hamrahian AH et al (2005) Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland Clinic experience. J Clin Endocrinol Metab 90(2):871–877
Heinz-Peer G et al (2007) Imaging of adrenal masses. Curr Opin Urol 17(1):32–38
Ilias I et al (2007) The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14(3):587–599
Szolar DH et al (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2):479–485
Park BK et al (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243(3):760–765
Honigschnabl S et al (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41(2):113–122
Al-Hawary MM et al (2005) Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 19(2):277–292
Faria JF et al (2007) Adrenal masses: characterization with in vivo proton MR spectroscopy – initial experience. Radiology 245(3):788–797
Groussin L et al (2009) 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94(5):1713–1722
Boland GW et al (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192(4):956–962
Okada M et al (2009) Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions. Ann Nucl Med 23(4):349–354
Leboulleux S et al (2006) Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 91(3):920–925
Mackie GC et al (2006) Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 91(7):2665–271
DeLellis RA et al (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs (IARC), Lyon, France, pp 136
Sullivan M et al (1978) Adrenal cortical carcinoma. J Urol 120(6):660–665
Quayle FJ et al (2007) Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery 142(4):497–502; discussion 502–504
Casola G et al (1986) Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology 159(3):733–735
Kloos RT et al (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484
Lumachi F et al (2001) Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors. Cancer 93(5):323–329
McCorkell SJ, Niles NL (1985) Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol 145(1):113–114
Yankaskas B et al (1986) Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest Radiol 21(4):325–328
Fassina AS et al (2000) Fine needle aspiration cytology (FNAC) of adrenal masses. Cytopathology 11(5):302–311
Habscheid W et al (1990) [Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication?]. Dtsch Med Wochenschr 115(6):212–215
Mody MK et al (1995) Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 19(3):434–439
de Agustin P, Lopez-Rios F et al (1999) Fine-needle aspiration biopsy of the adrenal glands: a ten-year experience. Diagn Cytopathol 21(2):92–97
Katz RL et al (1984) Fine needle aspiration cytology of the adrenal gland. Acta Cytol 28(3):269–282
Silverman SG et al (1993) Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 187(3):715–718
Wadih G et al (1992) Fine-needle aspiration cytology of the adrenal gland. Fifty biopsies in 48 patients. Arch Pathol Lab Med 116(8):841–846
Welch TJ et al (1994) Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193(2):341–344
Wu HH et al (1998) Fine needle aspiration cytology of benign adrenal cortical nodules. A comparison of cytologic findings with those of primary and metastatic adrenal malignancies. Acta Cytol 42(6):1352–1358
Ren R et al (2006) Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389–398
Lumachi F et al (2003) CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29(8):689–692
Saeger W et al (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34(2):180–186
Jhala NC et al (2004) Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients. Cancer 102(5):308–314
Haseganu LE, Diehl DL (2009) Left adrenal gland hemorrhage as a complication of EUS-FNA. Gastrointest Endosc 69(6):e51–52
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Allolio, B., Fassnacht, M. (2009). Clinical Presentation and Initial Diagnosis. In: Hammer, G., Else, T. (eds) Adrenocortical Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77236-3_4
Download citation
DOI: https://doi.org/10.1007/978-0-387-77236-3_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77235-6
Online ISBN: 978-0-387-77236-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)